A31.9
Mycobacterial infection, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Atypical mycobacterial infection NOS
- Mycobacteriosis NOS
Medical Intelligence & Overview
Mycobacterial infections are caused by bacteria belonging to the Mycobacterium genus. This group includes the bacteria responsible for tuberculosis and leprosy, but it also encompasses other, less common infections. When the specific type of mycobacterial infection is not identified or classified, it is referred to as an unspecified mycobacterial infection, coded as A31.9 in the ICD-10 system. This condition can affect various parts of the body, leading to a range of symptoms, and requires careful medical evaluation for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Exposure to atypical (non-tuberculous) mycobacteria present in soil, water, or environmental sources. Inhalation of contaminated aerosols containing mycobacteria. Inoculation through skin wounds or cuts that come into contact with contaminated materials. Weakening of the immune system, which increases susceptibility. Underlying health conditions such as chronic lung disease, HIV/AIDS, or immunosuppressive therapy.
Key Symptoms: Persistent cough, which may be dry or productive Fever, often low-grade or intermittent Unexplained weight loss Fatigue and general weakness Night sweats Localized swelling or lesions, especially in the skin or soft tissues Shortness of breath if lungs are involved Skin ulcers or nodules in cutaneous infections
Diagnostic & Treatment
Diagnosis Path: Medical history review and physical examination Imaging tests such as X-rays or CT scans to assess affected organs Laboratory tests including acid-fast bacilli (AFB) staining of tissue samples or fluids Culture of samples to identify the specific mycobacteria involved Molecular diagnostic tests like PCR for rapid detection Biopsy of affected tissue to examine cellular changes
Treatment Protocols: Combination antibiotic therapy, often including macrolides, rifamycins, or ethambutol Monitoring for drug side effects and response to treatment Supportive care to manage symptoms and prevent complications Addressing underlying health conditions to improve immune function Regular follow-up to assess treatment effectiveness and make adjustments as needed
Clinical Advice & FAQs
Billing Guidance
Is A31.9 a billable ICD-10 code?
Yes, A31.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A31.9?
Clinical documentation must specify the nature of Mycobacterial infection, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference